Insight / Operator brief

Software as a Medical Service Changes the Reimbursement Conversation

CMS is proposing an interim approach for software-based medical services with algorithmic analysis. The opening is important, but the category will reward products that can prove incremental clinical value, cost, workflow fit, and auditable use.

Return to insights

Healthcare software founders, digital health investors, hospital leaders, product teams, and reimbursement strategists / 2026-07-19

By Healthcare growth and AI operations executive

Founder question

What must a software-based medical service prove beyond technical performance to earn a durable place in payment and care delivery?

Public factsOperator interpretationBuyer implicationsFounder action

CMS's SaMS approach is proposed and subject to change. This brief is strategic analysis, not coding, billing, clinical, or legal advice.

Executive thesis

Source-backed operator read.

CMS's proposed Software as a Medical Service language is a category signal, not a finished business model. It begins to recognize that algorithmic software can perform clinically meaningful work that does not fit cleanly into a traditional device or labor-based payment frame. The companies positioned to benefit will be those that connect intended use, clinical evidence, workflow, documentation, cost, coding, and utilization into a service the system can evaluate and defend.

Public facts

  1. CMS stated in July 2026 that the CY 2027 OPPS proposed rule recognizes Software as a Medical Service as software-based technologies supporting clinical decision making through algorithmic analysis, including clinical or diagnostic functionality.

  2. CMS described the proposal as a first step toward pricing approaches for new technologies and said it is seeking to understand their incremental value.

  3. The CY 2027 OPPS proposal includes an interim payment policy discussion for software-based medical services with algorithmic analyses, including services assigned to New Technology APCs.

Operator read

  1. The category reframes software from a license to a medical service, which raises the importance of service definition, clinical accountability, evidence, and utilization management.

  2. Incremental value will be the hard question. A strong algorithm is not enough if the result duplicates existing work, creates downstream utilization, or lacks evidence of changed care.

  3. Billing architecture will shape product architecture. Documentation, user role, timing, setting, and claim evidence must be designed into the workflow.

  4. The commercial strategy should preserve multiple paths because the proposed policy may evolve and payer adoption may differ.

Operating model

Turn the thesis into a decision system.

The framework defines the work; the metrics define whether the work is creating value.

Operating framework

  1. 01

    Define the medical service, eligible setting, accountable clinician, decision, and incremental clinical value.

  2. 02

    Build evidence that separates the software contribution from the surrounding procedure and workflow.

  3. 03

    Map coding, billing, documentation, utilization, and audit evidence into the product requirements.

  4. 04

    Model cost and value across the provider, payer, patient, and delivery system.

  5. 05

    Treat reimbursement as a staged evidence program, not a pricing shortcut.

Metrics that matter

  1. 01

    Incremental clinical or diagnostic value

  2. 02

    Time and work added or removed from the care team

  3. 03

    Utilization and downstream care impact

  4. 04

    Claim acceptance and documentation completeness

  5. 05

    Total cost per completed and clinically useful service

Buyer implications

  1. Founders should build a reimbursement evidence plan before making SaMS a revenue forecast.

  2. Hospitals should evaluate clinical value, workflow burden, utilization, documentation, and auditability together.

  3. Investors should separate category recognition from coverage, coding, payment level, adoption, and margin.

Founder actions

  1. Write the complete service definition and accountable workflow.

  2. Build an incremental-value evidence map across clinical, operational, and economic outcomes.

  3. Prototype documentation and claim evidence with provider partners.

  4. Model direct payment, bundled value, enterprise licensing, and payer-contract alternatives.

Red flags

  1. The company equates a proposed category with guaranteed coverage or payment.

  2. Technical validation is presented as proof of incremental clinical value.

  3. The billing and documentation workflow is disconnected from product design.

CEO and CFO questions

  1. What service is being paid for, and who is accountable for it?

  2. What incremental value can be attributed to the software?

  3. Which documentation proves the service was medically useful and correctly delivered?

  4. How does the economics work if payment, utilization, or evidence requirements change?

Healthcare AI consulting and implementationHealthcare product and application developmentSpecialty infusion market intelligenceHealthcare AI consulting and implementationHealthcare product and application developmentSpecialty infusion market intelligenceHealthcare venture formation

Connect the service definition, evidence, workflow, reimbursement, and commercialization paths before committing the roadmap.

Design the SaMS evidence path

Start a serious conversation

Use the market signal before it becomes consensus.

Discuss an operating mandate